Anas A

As Founder and CEO of MultiOmics Intelligence, I lead the overall vision, strategy, and development of the company as an umbrella platform bringing together artificial intelligence, bioinformatics, multi-omics, molecular medicine, precision health, education, and digital health innovation.

My role includes directing our research and development activities, including AI-driven multi-omics analysis, cancer research, single-cell bioinformatics, biomarker discovery, and computational biology. I also oversee the development of our bioinformatics services, Clinical and PharmaOmics Consultancy, and the future launch of BioOmics Health and MultiOmics Academy.

I hold a BPharm in Pharmacy and an MSc in Clinical Biochemistry from the University of Surrey, where my research investigated novel mechanisms of cisplatin drug resistance in head and neck cancer. I also bring doctoral-level expertise in Cancer Biochemical Engineering from Brunel University of London, with a specialist focus on multi-omics data analysis and AI-driven approaches.

Alongside my scientific career, I am an accomplished Sales Strategic Manager with a strong track record in driving performance, optimising KPIs, and leading high-performing teams.

Overall, I bring together scientific depth, strategic thinking, commercial leadership, and digital innovation to build MultiOmics Intelligence as a connected ecosystem that transforms complex biological data into meaningful real-world impact.